Tampace-D Tablets
COMPOSITION – Tamsulosin HCL IP 0.4mg + Dutasteride 0.5mg
- More effective for the treatment of symptomatic benign prostatic hyperplasia than either drug alone
- Reduces the risk of developing acute urinary retention and need for surgery in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement
- Reduces symptoms of BPH, improves urinary flow and reduces prostate size in benign prostatic hyperplasia
- Provides better improvement of IPSS obstructive symptoms, UFR and reduction in PVRU than observed with the Tamsulosin and Finasteride
- More effectively provides greater degree of benefit in men with moderate to severe lower urinary tract symptoms and prostate enlargement
